Atlas Trials

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer

Clinical trial NCT03756090 · UNKNOWN

Trial details

NCT number
NCT03756090
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerBreast DiseasesBreast Neoplasms
Start date
2018-12-01
Primary completion
2019-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.